Hyaluronic Acid
Hyaluronic acid (HA) is a large, non-sulfated glycosaminoglycan built from repeating units of glucuronic acid and N-acetylglucosamine. It is abundant in connective tissues, skin, synovial fluid and the vitreous of the eye. Because the molecule strongly binds water, it contributes to tissue hydration, lubrication and the mechanical properties of extracellular matrices.
Tissue distribution and aging. HA content and organization change with age. In skin, these changes contribute to reduced hydration, elasticity and dermal volume. In joints, altered concentration and molecular weight of HA in synovial fluid can reduce lubrication. Age-related changes are influenced not only by total HA abundance but also by synthesis, degradation by hyaluronidases and the size distribution of HA fragments.
Molecular weight matters. High-molecular-weight HA generally behaves as a structural and anti-inflammatory matrix component, while smaller fragments can act as signaling molecules and in some contexts stimulate inflammatory pathways through receptors such as CD44 and Toll-like receptors. This size-dependent biology explains why different HA preparations may produce different effects despite sharing the same basic chemical building blocks.
Oral bioavailability. Large HA molecules taken orally are extensively broken down in the gastrointestinal tract, including by the gut microbiota. Only a small fraction reaches the circulation intact. Animal work suggests that bacterial degradation produces smaller oligosaccharides that can be absorbed or further metabolized. Therefore, effects of oral HA do not require large intact HA molecules to travel directly from the gut to skin or cartilage.
Skin. Topical HA is widely used as a humectant because it increases water retention at the skin surface. Injectable HA fillers provide a more direct volumizing effect by placing a viscoelastic material within the dermis or subcutaneous tissue. Randomized oral-supplement studies have also reported modest improvements in skin hydration, elasticity and wrinkle measures after several weeks, although products differ in molecular weight, dose and formulation.
HA also interacts with fibroblasts and extracellular-matrix signaling. Experimental work suggests that certain HA matrices can stimulate collagen synthesis and influence wound-healing responses. These effects are biologically plausible but should be distinguished from the immediate water-binding and filling effects that account for much of HA's visible cosmetic action.
Joints and osteoarthritis. Intra-articular HA injections are used as viscosupplementation in osteoarthritis. The goal is to improve synovial-fluid mechanics and potentially influence local inflammatory and nociceptive signaling. Clinical trial results are heterogeneous: some patients experience meaningful pain relief, while average benefits across trials are usually modest and depend on product, disease severity and comparator. HA does not reliably regenerate lost cartilage.
Eyes and mucosal surfaces. HA is a common component of lubricating eye drops because its water-binding and viscoelastic properties help stabilize the tear film and relieve dry-eye symptoms. Similar physical properties are useful in wound dressings and selected mucosal applications.
Inflammation and oxidative stress. High-molecular-weight HA can suppress inflammatory signaling in experimental systems, while low-molecular-weight fragments can have the opposite effect. HA can also interact with reactive oxygen species and may contribute to local antioxidant protection. These effects are context dependent and do not imply that HA acts as a systemic anti-aging antioxidant when taken as a supplement.
Safety. Oral and topical HA are generally well tolerated. Injectable products carry procedure-specific risks including bruising, swelling, nodules, infection and, rarely, vascular occlusion when filler enters or compresses a blood vessel. Intra-articular injections can cause transient pain or swelling and, rarely, inflammatory reactions or infection.
Overall, hyaluronic acid has well-established structural and clinical roles in tissue hydration, ophthalmic lubrication and injectable applications. Oral supplementation may modestly improve skin or joint outcomes in some people, but the strongest evidence for HA relates to its physical and local biological properties rather than to systemic longevity effects.